Target intelligence / Profile preview

Integrator complex subunit 7 (INTS7)

Target
INTS7
Molecular classification
Other (subunit of a multimeric RNA-processing protein complex) [1][3], Integrator complex subunit (non-enzymatic, non-receptor)
01

Overview

Integrator complex subunit 7 (INTS7) is a protein-coding gene that encodes a core component of the Integrator complex, which regulates RNA polymerase II–dependent transcription by mediating 3'-end processing of small nuclear RNAs such as U1 and U2 snRNAs. The Integrator complex forms a scaffold for both nuclease and phosphatase modules, and INTS7 is part of the backbone module together with INTS1 and INTS2. INTS7 is implicated in cellular responses to DNA damage where it participates in ATR signaling, and its expression is associated with disease aggressiveness in cancer types such as prostate and gastric cancer. It also modulates bone marrow mesenchymal stem cell differentiation and proliferation, indicating roles outside of classic RNA processing. INTS7 is not itself an enzyme, receptor, transporter, or current therapeutic target; it functions as an essential structural protein within a much larger multiprotein complex [1][2][3].

Other names
INTS7C1orf73INT7DKFZP434B168
02

Mechanism of action

Not applicable; INTS7 is not an established drug target. Its function is as part of a protein complex, not as a direct target of small molecules or biologics [1][3].

03

Biological functions

RNA processing (3'-end processing of small nuclear RNAs, especially U1 and U2 snRNAs) [1][2][3]Scaffold module for Integrator complexDNA damage response signaling [1][3]Regulation of gene expression via association with RNA polymerase II [2]Influences bone marrow mesenchymal stem cell differentiation and proliferation [1]
04

Disease associations

Cancer (elevated expression correlated with aggressive prostate cancer phenotype) [1]Gastric cancer [3]Osteoporosis (through roles in bone remodeling) [1]Involvement in DNA damage/repair processes (potential relevance for cancer and viral infection biology) [1]Viral infection (activation of ATR pathway during viral genome replication) [1]
05

Safety considerations

None specifically described; therapeutic intervention not established, so no known safety concerns related to targeting INTS7 [1][3].
06

Biomarkers

Elevated INTS7 expression as a potential biomarker for aggressive prostate cancer [1]Possible use in distinguishing bone marrow stem cell differentiation state [1]

Beyond the preview

Go deeper on Integrator complex subunit 7 (INTS7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrator complex subunit 7 (INTS7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call